Retour
Fourchette du Jour
97,79 €
100,72 €
Fourchette 52 Semaines
89,75 €
124,44 €
Volume
202 812
Moyenne 50J / 200J
106,92 €
/
111,86 €
Clôture Précédente
99,78 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,3 | 0,3 |
| P/B | 1,7 | 2,9 |
| ROE % | 9,3 | 3,7 |
| Net Margin % | 6,7 | 3,8 |
| Rev Growth 5Y % | 13,3 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
128,67 €
+29.6%
Low: 112,00 €
High: 139,00 €
P/E Prévisionnel
14,4
BPA Prévisionnel
6,91 €
Croissance BPA (est.)
+0,0%
CA Est.
1,5 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
8,08 €
7,00 € – 8,93 €
|
1,7 B | 3 |
| FY2027 |
7,47 €
7,29 € – 7,58 €
|
1,6 B | 7 |
| FY2026 |
6,91 €
6,83 € – 6,95 €
|
1,5 B | 8 |
Points Clés
Revenue grew 13,26% annually over 5 years — strong growth
Earnings grew 30,32% over the past year
Debt/Equity of 0,19 — conservative balance sheet
Negative free cash flow of 0,0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9,95%
Capital efficient — spends only 7,84% of revenue on capex
Croissance
Revenue Growth (5Y)
13,26%
Revenue (1Y)23,21%
Earnings (1Y)30,32%
FCF Growth (3Y)N/A
Qualité
Return on Equity
9,33%
ROIC8,03%
Net Margin6,74%
Op. Margin9,74%
Sécurité
Debt / Equity
0,19
Current Ratio1,80
Interest Coverage14,46
Valorisation
P/E Ratio
19,30
P/B Ratio1,71
EV/EBITDA14,27
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23,21% | Revenue Growth (3Y) | 15,92% |
| Earnings Growth (1Y) | 30,32% | Earnings Growth (3Y) | 23,86% |
| Revenue Growth (5Y) | 13,26% | Earnings Growth (5Y) | 20,74% |
| Profitability | |||
| Revenue (TTM) | 1,42B | Net Income (TTM) | 95,91M |
| ROE | 9,33% | ROA | 6,67% |
| Gross Margin | 32,47% | Operating Margin | 9,74% |
| Net Margin | 6,74% | Free Cash Flow (TTM) | 0,0 |
| ROIC | 8,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,19 | Current Ratio | 1,80 |
| Interest Coverage | 14,46 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 19,30 | P/B Ratio | 1,71 |
| P/S Ratio | 1,30 | PEG Ratio | 1,04 |
| EV/EBITDA | 14,27 | Dividend Yield | 0,00% |
| Market Cap | 1,85B | Enterprise Value | 1,98B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,42B | 1,15B | 1,06B | 951,12M | 864,50M |
| Net Income | 95,91M | 73,60M | 62,52M | 46,03M | 45,13M |
| EPS (Diluted) | 5,21 | 4,23 | 3,83 | 2,84 | 2,81 |
| Gross Profit | 461,87M | 375,02M | 339,88M | 299,74M | 269,85M |
| Operating Income | 138,62M | 102,69M | 90,96M | 68,74M | 65,94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,44B | 1,41B | 1,02B | 937,99M | 947,59M |
| Total Liabilities | 352,01M | 442,14M | 317,73M | 304,45M | 373,24M |
| Shareholders' Equity | 1,09B | 970,49M | 706,69M | 633,54M | 574,34M |
| Total Debt | 208,62M | 273,13M | 175,18M | 178,05M | 263,55M |
| Cash & Equivalents | 81,62M | 98,91M | 64,79M | 79,96M | 168,90M |
| Current Assets | 269,49M | 260,38M | 200,00M | 222,81M | 324,34M |
| Current Liabilities | 149,49M | 155,87M | 145,12M | 131,15M | 117,69M |